Personalized Microbiome-Based Approaches to Early Onset Colorectal Cancer Prevention, Diagnosis and Management - SP2: Unravel the tumor microbiome and mycobiome and its implication for oncogenic signaling (PerMiCCion)

Basic data for this project

Type of projectParticipation in federally funded joint project
Duration at the University of Münster01/04/2022 - 31/03/2026 | 1st Funding period

Description

KeywordsDarmkrebs
Website of the projecthttp://www.permiccion.de/
Funding identifier01KD2101F
Funder / funding scheme
  • Federal Ministry of Research, Technology and Space (BMFTR)

Project management at the University of Münster

Bleckmann, Annalen

Applicants from the University of Münster

Bleckmann, Annalen

Research associates from the University of Münster

Menck, Kerstin

Project partners outside the University of Münster

  • University of BonnGermany
  • Jena University Hospital (UKJ)Germany
  • Heidelberg University Hospital (UKH)Germany
  • University Medical Center Freiburg (UKF)Germany
  • University Medical Center Göttingen (UMG)Germany
  • Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI)Germany
  • Josephs-Hospital Warendorf (JHW)Germany
  • Bio-mENorway
  • DNANutriCoachSpain
  • Genetic Analysis AS (GA)Norway
  • SNIPR BiomeDenmark

Coordinating organisations outside the University of Münster

  • Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (Leibniz-HKI)Germany

Publications of the University of Münster resulting from the project

Richter, Katharina Maria; Wrage, Marius; Krekeler, Carolin; De Oliveira, Tiago; Conradi, Lena-Christin; Menck, Kerstin; Bleckmann, Annalen (2025)
In: EMBO Molecular Medicine17(3)395-413. doi:10.1038/s44321-025-00198-3
Review article (journal) | Peer reviewed | Published